Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. EPIDYOLEX
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

EPIDYOLEX

Medicine - Posted on Jan 10 2022
Active substance (DCI)
  • cannabidiol
history (2)
  • 12/1/21

    EPIDYOLEX 100 mg/ml (cannabidiol)

    Key points Favourable opinion for reimbursement as adjunctive therapy of seizures associated with tuberous sclerosis complex...
    CAV :
    54321
    icône flèche
  • Economic analysis
    5/13/20

    EPIDYOLEX

    First assessment. Favourable opinion for reimbursement as adjunctive therapy of seizures associated with Lennox-Gastaut synd...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • N03AX24
Manufacturer
GW PHARMA
Presentation

EPIDYOLEX 100 mg/ml, solution buvable
1 flacon en verre de 100 ml + 2 seringues de 1 ml + 2 seringues de 5 ml + 2 adaptateurs de flacon - (Code CIP : 34009 301 879 6 8)

All our publications
    Central nervous system diseases Drug therapy Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
74n4NDtTTrdpQHJY